Table 1.
Patient clinico-biochemical features
| Variables | Metabolic syndrome (n = 150) | No metabolic syndrome (n = 154) | P |
|---|---|---|---|
| Age (years) | 63.0 ± 4.1 | 62.9 ± 4.8 | 0.751 |
| BMI (kg/m2) | 25.4 ± 2.9 | 22.5 ± 3.0 | <0.001 |
| Waist circumference (cm) | 88.3 ± 5.2 | 81.9 ± 2.5 | 0.001 |
| FBG (mM) | 7.1 ± 1.4 | 5.2 ± 0.7 | <0.001 |
| HbA1C (%) | 6.7 ± 0.9 | 5.2 ± 0.4 | 0.003 |
| Systolic blood pressure (mmHg) | 148.1 ± 6.9 | 122.1 ± 4.9 | <0.001 |
| Diastolic blood pressure (mmHg) | 92.3 ± 4.5 | 71.8 ± 5.7 | 0.002 |
| Triglycerides (mM) | 2.4 ± 1.1 | 1.8 ± 1.2 | <0.001 |
| Total cholesterol (mM) | 5.1 ± 1.0 | 4.6 ± 1.1 | <0.001 |
| HDL-C (mM) | 1.0 ± 0.1 | 1.3 ± 0.1 | <0.001 |
| LDL-C (mM) | 3.1 ± 0.9 | 2.8 ± 0.6 | 0.008 |
| NAFLD (%) | 110(73.3) | 33 (21.4) | <0.001 |
| Fasting serum insulin (μIU/mL) | 14.3 ± 7.2 | 9.2 ± 5.0 | <0.001 |
| Estradiol (pg/ml) | 23.2 ± 7.2 | 27.0 ± 7.2 | <0.001 |
| HOMA-IR | 3.5 ± 1.8 | 2.1 ± 1.3 | <0.001 |
Abbreviations BMI body mass index, FBG fasting blood glucose, HbA1C hemoglobin A1C, HDL high density lipoprotein, LDL low-density lipoprotein, NAFLD nonalcoholic fatty liver disease
Data are mean ± SD. Comparisons were performed by t-test
p < 0.05 indicates a significant difference from the normal control